Geron Co. (NASDAQ:GERN – Get Rating) Director V Bryan Lawlis sold 35,000 shares of the firm’s stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $3.00, for a total value of $105,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through […]
Geron (NASDAQ:GERN – Get Rating) released its earnings results on Thursday. The biopharmaceutical company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02, RTT News reports. Geron had a negative net margin of 23,808.89% and a negative return on equity of 132.71%. The company had revenue of $0.02 million for […]
Geron (NASDAQ:GERN – Get Rating) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02, RTT News reports. The firm had revenue of $0.02 million for the quarter, compared to analysts’ expectations of $0.14 million. Geron had a […]
Geron Co. (NASDAQ:GERN – Get Rating) Director Susan Molineaux sold 35,000 shares of the company’s stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $2.48, for a total value of $86,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]
Shares of Geron Co. (NASDAQ:GERN – Get Rating) have earned a consensus recommendation of “Hold” from the six brokerages that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have given a buy recommendation to the […]